Mostrar el registro sencillo del ítem
Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain)
| dc.contributor.author | Lope, Virginia | |
| dc.contributor.author | Castelló, Adela | |
| dc.contributor.author | Mena Bravo, Antonio | |
| dc.contributor.author | Fernández Tardón, Guillermo | |
| dc.date.accessioned | 2018-10-08T10:23:25Z | |
| dc.date.available | 2018-10-08T10:23:25Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Journal of Steroid Biochemistry and Molecular Biology, 182, p. 4-13 (2018); doi:10.1016/j.jsbmb.2018.04.005 | |
| dc.identifier.issn | 0960-0760 | |
| dc.identifier.uri | http://hdl.handle.net/10651/48861 | |
| dc.description.sponsorship | The study was funded by Carlos III Institute of Health grants (PI12/00488, PI12/00265, PI12/00715, PI12/01270, PI09/00773 and PI08/1770), by the Spanish Ministry of Health (EC11-273), by the SpanishMinistry of Economy and Competitiveness (IJCI-2014-20900) and byConsejería de Salud de la Junta de Andalucía (PI-0571-2009) compe-titive calls including peer review for scientific quality. Additionalfunding was provided by the Spanish Federation of Breast CancerPatients (FECMA: EPY 1169-10), the Association of Women with BreastCancer from Elche (AMACMEC: EPY 1394/15), the Marqués deValdecilla foundation (grant API 10/09), and by Acción Transversal delCancer, approved by the Spanish Ministry Council on October 11, 2007. | |
| dc.description.statementofresponsibility | Lope, V., Castelló, A., Mena-Bravo, A., Amiano, P., Aragonés, N., Fernández-Villa, T., Guevara, M., Dierssen-Sotos, T., Fernandez-Tardón, G., Castaño-Vinyals, G., Marcos-Gragera, R., Moreno, V., Salas-Trejo, D., Diaz-Santos, M., Oribe, M., Romieu, I., Kogevinas, M., Priego-Capote, F., Pérez-Gómez, B., Pollán, M. | |
| dc.format.extent | p. 4-13 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Steroid Biochemistry and Molecular Biology, 182 | |
| dc.rights | © 2018 Elsevier Ltd. | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046146114&doi=10.1016%2fj.jsbmb.2018.04.005&partnerID=40&md5=456d7555a2cc3aae59d6105633062308 | |
| dc.title | Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain) | |
| dc.type | journal article | |
| dc.identifier.doi | 10.1016/j.jsbmb.2018.04.005 | |
| dc.relation.projectID | ISCIII/PI12/00265 | |
| dc.relation.projectID | ISCIII/PI12/01270 | |
| dc.relation.projectID | MINECO/IJCI-2014-2090 | |
| dc.relation.projectID | FECMA/EPY 1169-1 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1016/j.jsbmb.2018.04.005 |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [36307]